We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Gunna Drinks (GD) manufactures and sells craft soft drinks, consisting of natural juices with less than 5% sugar having zero artificial colours or flavours. The company asserts that it has outshone established competitors like Gingerella, Fentimans and FeverTree in taste tests. GD is stocked in major supermarkets and convenience stores across the UK such as Co-ops, Sainsbury’s, Amazon, Ocado, and JD Wetherspoon. The company won the prestigious 'Great Taste Award' in 2020 and witnessed more than doubled revenues in 2018-2020, with a 23% growth in 2020 despite COVID. The company will utilise the investment to boost consumer advertising to accelerate the growth of its online store, focus on trade investment to further increase the rate of sale, and concentrate on New Product Development (NPD).

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £696,261
JOHNNY'S is an ethical, vegan, and sex-positive subscription condom brand. The company aims to deliver its products on a subscription basis, following in the footsteps of Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aims to become a contender in the global condom market that is set to be worth $15 Billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go: Expired investment: £182,281
A hardware designer and manufacturer specialising in innovative tools and equipment for yachts. Ark Marine have developed a solution for modern yachts to lift and launch dinghies with ease from a simple pushbutton operated system. According to the team's research, the product market could be potentially valued at over £600m. The company is a member of British Marine and has submitted patents for approval for developments in the future.
days to go: Expired investment: £108,590
Njori is a company that has created an accurate, multi-functional cooker that can be stored on a bookshelf alongside cookbooks. The cooker uses integrated sensors and accessories to monitor and regulate the cooking process. It's built-in scales helps a user measure ingredients before and during the cooking process. The scale function also enables the user to reduce food by a set weight or percentage. The company aims to be a disruptor in the global portable induction cooker market that is set to be worth £4.5 billion by 2022. Njori has filed UK patents & is building its supply chain in China. It will use the investment to finish development and bring the final product to market.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £236,797
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £103,672
Ubiqutek is pioneering the use of electricity in the weed control market. http://ubiqutek.com/ 
days to go: Expired investment: £133,065
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph